Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn an additional $0.7 with the CVR.
Indian drug major Sun Pharmaceutical Industries (BSE: 524715) has entered an agreement with Checkpoint Therapeutics (Nasdaq: CKPT) to acquire the US immunotherapy and targeted oncology company, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results